APA

Stams W. A. G., den Boer M. L., Beverloo H. B., Meijerink J. P. P., van Wering E. R., Janka-Schaub G. E. & Pieters R. (20050829). Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Stams Wendy A G, den Boer Monique L, Beverloo H Berna, Meijerink Jules P P, van Wering Elisabeth R, Janka-Schaub Gritta E and Pieters Rob. 20050829. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Stams W. A. G., den Boer M. L., Beverloo H. B., Meijerink J. P. P., van Wering E. R., Janka-Schaub G. E. and Pieters R. (20050829). Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Stams Wendy A G, den Boer Monique L, Beverloo H Berna, Meijerink Jules P P, van Wering Elisabeth R, Janka-Schaub Gritta E and Pieters Rob. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20050829.